Moreover, in multiple experimental mouse models of colitis, administration of Ficz subsequently caused IL-22 induction, whereas administration of an AhR antagonist resulted in more severe colitis with decreased IL-22 production (Monteleone et al., 2011). Here, IL22 is linked to colitis.